|
|
Senior Scientist, Clinical Epidemiology, Ottawa Hospital Research Institute
Professor, Department of Medicine and Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa
Physician, Division of Infectious Diseases, Department of Medicine, The Ottawa Hospital
Most Recent Publications (provided by The Ottawa Hospital Library Database)
Schreiber YS;Herrera AF;Wilson D;Wallengren K;Draper R;Muller J;Dawood H;Doucette S;Cameron DW;Alvarez GG;, (2009 Oct), Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area, Int J Tuberc Lung Dis, Vol.13, Issue 10, 1274-1280 -> view abstract
Anis AH;Nosyk B;Sun H;Guh DP;Bansback N;Li X;Barnett PG;Joyce V;Swanson KM;Kyriakides TC;Holodniy M;Cameron DW;Brown ST;, (2009 May 7), Quality of Life of Patients With Advanced HIV/AIDS: Measuring the Impact of Both AIDS-Defining Events and Non-AIDS Serious Adverse Events, J Acquir Immune Defic Syndr , Issue 7-May, -> view abstract
Clark M;Cameron DW;, (2009 Jan 28), Tuberculosis elimination in the Canadian First Nations population: assessment by a state-transfer, compartmental epidemic model, International Journal of Infectious Diseases, Vol.13, Issue 2, 220-226 -> view abstract
la Porte CJ;Sabo JP;Beique L;Cameron DW;, (2009 Aug 31), Lack of effect of efavirenz on the pharmacokinetics of tipranavir/ritonavir (TPV/r) in healthy volunteers, Antimicrob Agents Chemother , -> view abstract
Pham PA;la Porte CJ;Lee LS;van Heeswijk R;Sabo JP;Elgadi MM;Piliero PJ;Barditch-Crovo P;Fuchs E;Flexner C;Cameron DW;, (2009 Aug 10), Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers, Antimicrob Agents Chemother , -> view abstract
La Porte CJL;Sabo JP;Elgadi M;Cameron DW;, (2009), Interaction studies of tipranavir-ritonavir with clarithromycin, fluconazole, and rifabutin in healthy volunteers, Antimicrobial Agents and Chemotherapy, Vol.53, Issue 1, 162-173 -> view abstract
la Porte C;Sabo JP;Elgadi M;Cameron DW;, (2008 Nov 17), Interaction studies of tipranavir/ritonavir (TPV/r) with clarithromycin, fluconazole and rifabutin in healthy volunteers, Antimicrob Agents Chemother , Vol.53, Issue 1, 162-173 -> view abstract
Gulzar N;Diker B;Mihowich J;Deschatelets J;Arsenault ME;Lamoureux N;Cameron DW;Kim JE;Copeland KF;, (2008 Nov), Proportion of HIV-1 infected CD8+CD4- T lymphocytes in vivo, Current HIV Research, Vol.6, Issue 6, 585-596 -> view abstract
Cameron DW;da Silva BA;Arribas JR;Myers RA;Bellos NC;Gilmore N;King MS;Bernstein BM;Brun SC;Hanna GJ;, (2008 Jun 9), A 96-Week Comparison of Lopinavir-Ritonavir Combination Therapy Followed by Lopinavir-Ritonavir Monotherapy versus Efavirenz Combination Therapy, J Infect Dis, Vol.198, Issue 2, 234-240 -> view abstract
Angel JB;Cooper CL;Clinch J;Young CD;Chenier A;Parato KG;Lautru M;Davis H;Cameron DW;, (2008 Aug 12), CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection, J Immune Based Ther Vaccines , Vol.6, Issue 1, 4 -> view abstract
Note: This is not a complete list of publications. More publications may be available in The Ottawa Hospital Library database and Pubmed (search by last name and initials).
| |
General Campus
(see 
